Globus Medial completed its acquisition of Nevero, a spinal cord stimulator company, according to an April 3 news release.

Globus Medical has completed its acquisition of Nevro, broadening its market presence in musculoskeletal solutions.

Globus Medial completed its acquisition of Nevero, a spinal cord stimulator company, according to an April 3 news release.

Globus Medical (NYSE:GMED) announced today that that it completed its previously announced acquisition of Nevro.

Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal technology company, today announced the completion of its ...

The market includes spinal cord stimulation (SCS) systems as well as peripheral nerve stimulation (PNS) systems - ...

StockNews.com assumed coverage on shares of Nevro (NYSE:NVRO – Free Report) in a report issued on Sunday. The brokerage issued a hold rating on the medical equipment provider’s stock. Other equities ...

Shares of Nevro Corp. (NYSE:NVRO – Get Free Report) have earned a consensus rating of “Reduce” from the thirteen brokerages that are presently covering the firm, Marketbeat.com reports. Two investment ...

Spinal cord stimulators have grown in popularity over the past several years as patients see benefits in the less-invasive ...

REDWOOD CITY, Calif.--(BUSINESS WIRE)-- Arcellx, Inc. (NASDAQ: ACLX), a biotechnology company reimagining cell therapy through the development of innovative immunotherapies for patients with ...

Most recently, Mr. Galligan served as Chief Financial Officer at Nevro Corp., a medical device company in the implantable spinal cord stimulation market. During his 10-year tenure at Nevro, he built ...

Nevro NVRO is well-poised for growth in ... However, concerns regarding softness in the spinal cord stimulation (SCS) market and dependence on third-party payers persist. This Zacks Rank #3 ...